ASPEN PHARMACARE HOLDINGS LIMITED - No Change Statement and Notice of Annual General Meeting 6 December 2016
APN 201611040032A
No Change Statement and Notice of Annual General Meeting – 6 December 2016
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen Holdings" or "the Company")
NO CHANGE STATEMENT AND NOTICE OF ANNUAL GENERAL MEETING
– 6 DECEMBER 2016
Shareholders are advised that the Company’s Integrated Report for the year ended 30 June 2016 has
been finalised and that this report and the notice of the annual general meeting (“AGM”) to be held
at its Durban offices on 6 December 2016 is being posted to shareholders. The Integrated Report,
notice of AGM and the following documents are also available online at the Company’s website
www.aspenpharma.com:
- Unabridged Corporate Governance Statement and reports of the Aspen Audit & Risk and
Social & Ethics committees for the 2016 financial year; and
- the Annual Financial Statements for the 2016 financial year (“AFS”).
The AFS contain no modifications to the reviewed provisional results which were published on
SENS on 14 September 2016. The AFS were audited by PricewaterhouseCoopers Inc. Their
unqualified report is available for inspection at the Company’s registered office.
Notice is hereby given that the 18th annual general meeting of the shareholders of the Company will
be held at Aspen Place, 9 Rydall Vale Park, Douglas Saunders Drive, La Lucia Ridge Office Park,
Durban, Kwa-Zulu Natal, on Tuesday, 6 December 2016 at 10:00.
Shareholders who, for whatever reason, experience postal delays and who do not receive the
notice of the AGM in time to submit proxy forms to the Company’s share transfer secretaries
(Trifecta Capital) are requested to access the notice of AGM and other documents referred to
above on the Company’s website www.aspenpharma.com. A printable version of these
documents in PDF format can also be emailed to shareholders upon request to the Company
Secretary – rverster@aspenpharma.com or +27 31 580 8624.
Durban
4 November 2016
Sponsor
Investec Bank Limited
Date: 04/11/2016 03:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
